LOUISVILLE, Ky. (WAVE) - Though a COVID-19 vaccine could be released by year’s end or soon after, healthcare professionals say getting it to everyone who needs it is expected to take over a year.

LOUISVILLE, Ky. (WAVE) - A new drug is being studied in our area to help dramatically reduce the symptoms of COVID-19. That drug is called Quellor. INmune BIO said if its drug is approved by the FDA, ...

Trial to evaluate the efficacy of Quellor™ to blunt the cytokine storm and decrease the catastrophic complications of COVID-19 infection. LA JOLLA, Sept. 01, 2020 (GLOBE NEWSWIRE) -- INmune Bio, Inc. ...

LA JOLLA, Calif, Nov. 09, 2020 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the, “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s ...

LOUISVILLE, Ky. (WDRB) -- Jewish Hospital has treated its first patient as part of a national study that hopes to prevent the progression of pulmonary complications due to COVID-19. According to ...

INmune Bio, a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, announced that the US Food and Drug Administration ...

SAN DIEGO (KGTV) — In some of the most severe cases of COVID-19, doctors are finding it’s not the coronavirus making people critically ill. It’s their own immune system, and a San Diego-based biotech ...

In some severe cases of COVID-19, it’s not the coronavirus making people critically ill. It’s their own immune system. A small San Diego company thinks it has an answer.

Trial to evaluate the efficacy of Quellor™ to blunt the cytokine storm and decrease the catastrophic complications of COVID-19 infection. “There is compelling evidence that TNF plays an outsized role ...